Our analysis shows that the development of BC IBTRs is dependent on both hormonal receptor status of the PT, as well as changes in the DNA replication and transcription machinery in tandem with APOBEC proteins to increase genomic instability, resulting in an increased mutational load. Here, NR4A1 is linked to breast cancer.